Dallas, Texas--(Newsfile Corp. - November 10, 2020) - Puration, Inc. (OTC Pink: PURA) ("PURA", "The Company") today announces the acquisition of a 72 Acre Property in line with launch of Farmersville Brands, a game-changing lifestyle brand focused on innovations in rapidly growing, multi-billion dollar hemp industry.
The Company has released a multimedia presentation detailing the exciting launch of their new lifestyle branded business initiative targeting the acquisition of hemp consumer advocates as participants in an innovative hemp-solution-development-ecosystem.
FULL PRESENTATION CAN BE VIEWED HERE:
Cannot view this video? Visit:
Farmersville Brands includes a dynamic platform that brings key hemp industry players including activists, engineers, medical professionals, entrepreneurs, investors and others as part of a 'hemp solutions development ecosystem' to conceive, pilot, and produce hemp solutions for mass or specialty consumption.
PURA acquired a 72-acre property from UC Asset LP as the foundation for the hemp-solution-development-ecosystem. The property, in Farmersville, Texas is the inspiration for the hemp lifestyle brand name, "Farmersville Brands."
Farmersville, Texas
To view an enhanced version of this image, please visit:
The Company has key partnerships in place to kick-off expedited success with Farmersville Brands, including a hemp-solution-development-ecosystem partnership with PAO Group, Inc. to participate in the co-development of hemp derived nutraceutical and pharmaceutical solutions.
As well, PURA has partnered with Alkame Holdings, Inc. to act as a dedicated copacker for hemp derived beverages, foods and oils, and The Company is currently engaged in several discussions with additional partnerships which will be detailed in forthcoming updates.
Attractive Opportunities in the Industrial Hemp Market
To view an enhanced version of this image, please visit:
U.S. Hemp CBD Market Size and Projections
To view an enhanced version of this image, please visit:
In an initiative to streamline operations toward consolidated growth and expedited increase in contracts and revenues, PURA is reorganizing its existing business concerns, contracts, and intellectual properties to parallel its reprioritization of efforts in conjunction with the new hemp lifestyle brand. As well, A corporate name change, and renovated website are currently underway.
In addition to the recent land purchase and new partnerships, PURA brings a host of historical momentum to the new hemp-solution-development-ecosystem business plan.
Puration's entrance into the cannabis sector was founded on its U.S. patented cannabis extraction process backed by extensive university medical research, with a license granted by NCM Biotech.
PURA U.S. patented extraction process backed by top university medical research
To view an enhanced version of this image, please visit:
In January of this year PURA launched an acquisition campaign targeting CBD product acquisitions that could be enhanced with PURA's patented technology. Those assets, including its CBD pet products business and CBD sun care business, along with the patented extraction process, will be valuable in propelling the hemp-solution-development-ecosystem business strategy forward.
PURA's new hemp-solution-development-ecosystem business will maintain its existing beverage business. PURA's EVERx CBD Sports Water remains a leader in the sports nutrition market place accounting for the lion's share of PURA's $2.7 million in revenue reported last year in 2019.
PURA’s EVERx CBD Sports Water
To view an enhanced version of this image, please visit:
Sign up to receive the latest updates at .
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
(800) 861-1350
To view the source version of this press release, please visit
